Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hingorani

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Cancer Cell|January 7, 2004
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouseSunil R Hingorani, Emanuel F Petricoin, Anirban Maitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic AdenocarcinomaEric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Science (New York, N.Y.)|May 23, 2009
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerKenneth P Olive, Michael A Jacobetz, Christian J Davidson, et al.
Kidney International|January 18, 2013
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A Gadegbeku, Debbie S Gipson, Lawrence B Holzman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Cancer Cell|January 7, 2004
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouseSunil R Hingorani, Emanuel F Petricoin, Anirban Maitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic AdenocarcinomaEric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Science (New York, N.Y.)|May 23, 2009
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerKenneth P Olive, Michael A Jacobetz, Christian J Davidson, et al.
Kidney International|January 18, 2013
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachCrystal A Gadegbeku, Debbie S Gipson, Lawrence B Holzman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2015
Complete Remission in the Nephrotic Syndrome Study NetworkDebbie S Gipson, Jonathan P Troost, Richard A Lafayette, et al.
Kidney International|November 28, 2022
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosisLaura H Mariani, Sean Eddy, Fadhl M AlAkwaa, et al.
Pageof 12